Form 4: Aspen Aerogels Executive Awarded Significant Equity

Aspen Aerogels' CAO, GC & Corp Secretary, Glenn E. Deegan, received significant equity awards including Restricted Stock Units, Stock Options, and Performance Share Units.

Summary

• Glenn E. Deegan, Chief Accounting Officer, General Counsel & Corporate Secretary of Aspen Aerogels Inc. (ASPN), was granted equity awards on September 30, 2025.
• The awards include 11,673 Restricted Stock Units (RSUs), which represent the right to receive one share of Common Stock upon vesting.
• Also granted were Stock Options to purchase 16,416 shares of Common Stock at an exercise price of $6.96 per share.
• Additionally, 23,347 Performance Share Units (PSUs) were awarded, representing a contingent right to receive Common Stock upon vesting.
• The RSUs and Stock Options vest in three equal annual installments, beginning September 30, 2026, and continuing on September 30, 2027, and September 30, 2028.
• The PSUs vest on March 5, 2028, following a performance period from January 1, 2025, to December 31, 2027, with vesting ranging from 0-200% of the target based on the company's total shareholder return relative to the Russell 2000 Index.

Sentiment

Score: 7

Explanation: The filing reflects a routine executive compensation event, which is generally positive for aligning management incentives with shareholder interests. It does not contain any unexpected negative information or significant new positive developments that would dramatically alter the company's outlook.

Positives

• The equity awards align the executive's long-term interests with those of the shareholders, incentivizing performance and retention.
• The performance-based nature of the PSUs directly links a portion of the executive's compensation to the company's relative stock performance against a market index.

Risks

• The value realized from the Performance Share Units is contingent on the company's total shareholder return relative to the Russell 2000 Index, introducing market and performance risk.
• The value of the Stock Options is dependent on the future market price of Aspen Aerogels' common stock exceeding the exercise price of $6.96.

Future Outlook

The future compensation for the executive, particularly from the Performance Share Units, is directly tied to Aspen Aerogels' total shareholder return relative to the Russell 2000 Index over a performance period ending December 31, 2027, with vesting occurring in March 2028. The vesting of RSUs and Stock Options extends through September 2028, indicating a long-term incentive structure.

Industry Context

This equity grant is a standard practice in the industry for executive compensation, aiming to align management incentives with long-term shareholder value creation. The use of performance-based units tied to a broad market index (Russell 2000) is a common mechanism to ensure compensation reflects relative outperformance.

Comparison to Industry Standards

• The structure of equity awards, including RSUs, stock options, and performance-based PSUs, is consistent with common executive compensation practices among publicly traded companies, particularly those in growth-oriented sectors.
• Tying PSU vesting to Total Shareholder Return (TSR) relative to a benchmark like the Russell 2000 Index is a widely adopted approach to incentivize competitive performance against peers, similar to practices seen in companies like XYZ Corp or ABC Inc. in their recent compensation disclosures.

Stakeholder Impact

• Shareholders: The equity awards align the executive's financial interests with long-term shareholder value creation, potentially leading to improved performance.
• Employees: Standard executive compensation practices can influence overall company morale and compensation structures.

Next Steps

• Vesting of Restricted Stock Units and Stock Options will occur in three annual installments on September 30, 2026, September 30, 2027, and September 30, 2028.
• The performance period for Performance Share Units will conclude on December 31, 2027.
• Performance Share Units are scheduled to vest on March 5, 2028, based on the company's total shareholder return relative to the Russell 2000 Index.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a senior executive, which is a standard component of executive compensation. It does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. The transaction is expected and primarily serves to align executive incentives with long-term shareholder value.

Keywords

Aspen Aerogels, ASPN, Form 4, Equity Award, Restricted Stock Units, RSU, Stock Options, Performance Share Units, PSU, Executive Compensation, Insider Transaction